Selection from HEOR Bibliography

IMS logo
Search criteria
Country: Netherlands
 
The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a
Authors: Hanne van Ballegooijen, Karin van der Hiele, Christian Enzinger, Gert de Voer, Leo H. Visser, on behalf of the CONFIDENCE Study Group
Affiliations: IQVIA Netherlands, Real World Evidence, Netherlands b Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, Netherlands c Medical University of Graz, Graz, Austria d Merck BV, Schiphol-Rijk, The Netherlands, an affiliate of Merck KGaA, Germany e St Elisabeth Tweesteden Hospital, Tilburg, the Netherlands
Publications: 
eNeurologicalSci, Volume 28, 2022, 100409, ISSN 2405-6502, https://doi.org/10.1016/j.ensci.2022.100409. (https://www.sciencedirect.com/science/article/pii/S2405650222000181)
Document Types: , Article
Countries: , Austria, Belgium, Netherlands , Slovakia
Abstract: https://www.sciencedirect.com/science/article/pii/S2405650222000181
Condition Year Language Analysis type
, Drug safety, Drug Utlization Study, Neurological disorders 2022 English , Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Population Based Study, Prospective study
 
 
Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study
Authors: Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V.
Affiliations: "Pfizer Inc., New York, New York, United States of America. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America. EPID Research (an IQVIA company), Espoo, Finland."
Publications: 
Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582
Document Types: , Article
Countries: , Denmark, Finland, Netherlands , Sweden, USA
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/pds.5582
Condition Year Language Analysis type
, Database Validity and methodology, Drug safety, Oncology 2022 English , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis
 
 
Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands
Authors: Hanne van Ballegooijen 1, Lucas Goossens 2, Ralph H Bruin 3, Renée Michels 3, Marieke Krol 3
Affiliations: 1IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. hanne.vanballegooijen@iqvia.com. 2Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands. 3IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands.
Publications: 
1 IQVIA, Herikerbergweg 314, 1101 CT Amsterdam, The Netherlands. 2 Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands
BMC Health Services Research (2021) 21:227
PMID: 33712010 PMCID: PMC7953179 DOI: 10.1186/s12913-021-06240-7
Document Types: , Article
Countries: , Netherlands
Abstract: https://pubmed.ncbi.nlm.nih.gov/33712010/
Condition Year Language Analysis type
, Health economics, Health status & patient reported outcomes, Immunology and Vaccination 2021 English , Observational study, Patient questionnaire, Population Based Study, Public Health, Quality of life, Survey research
 
 
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Authors: Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K
Affiliations: IQVIA, Eli Lilly
Publications: 
Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
Document Types: , Article
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31028689
Condition Year Language Analysis type
, Diabetes 2019 English , Retrospective database analysis
 
 
Copyright 2024 IMS Health Incorporated. All rights reserved.